These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

569 related items for PubMed ID: 15857352

  • 1. Venous thromboembolism in the medically ill patient: a call to action.
    Bergmann JF, Kher A.
    Int J Clin Pract; 2005 May; 59(5):555-61. PubMed ID: 15857352
    [Abstract] [Full Text] [Related]

  • 2. Prevention of venous thromboembolism in medically ill patients: a clinical update.
    Turpie AG, Leizorovicz A.
    Postgrad Med J; 2006 Dec; 82(974):806-9. PubMed ID: 17148703
    [Abstract] [Full Text] [Related]

  • 3. The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States.
    Caprini JA, Arcelus J, Sehgal LR, Cohen EB, Reyna JJ.
    Int Angiol; 2002 Mar; 21(1):78-85. PubMed ID: 11941278
    [Abstract] [Full Text] [Related]

  • 4. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS.
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [Abstract] [Full Text] [Related]

  • 5. Low molecular weight heparins in the prevention of venous thromboembolism in nonsurgical patients.
    Haas S.
    Semin Thromb Hemost; 1999 Nov; 25 Suppl 3():101-5. PubMed ID: 10549724
    [Abstract] [Full Text] [Related]

  • 6. [Prevention of venous thromboembolism in internal medicine and neurology].
    Malý J, Dulícek P, Penka M, Malý R, Gumulec J.
    Vnitr Lek; 2006 Mar; 52 Suppl 1():63-7. PubMed ID: 16637452
    [Abstract] [Full Text] [Related]

  • 7. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH, Muntz J.
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [Abstract] [Full Text] [Related]

  • 8. Venous thromboembolic risk and its prevention in hospitalized medical patients.
    Haas SK.
    Semin Thromb Hemost; 2002 Dec; 28(6):577-84. PubMed ID: 12536351
    [Abstract] [Full Text] [Related]

  • 9. Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin.
    Turpie AG, Norris TM.
    Thromb Haemost; 2004 Jul; 92(1):3-12. PubMed ID: 15213839
    [Abstract] [Full Text] [Related]

  • 10. Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients.
    McGarry LJ, Thompson D, Weinstein MC, Goldhaber SZ.
    Am J Manag Care; 2004 Sep; 10(9):632-42. PubMed ID: 15515996
    [Abstract] [Full Text] [Related]

  • 11. Prophylaxis against venous thromboembolism in acutely ill medical patients: an observational study.
    Peterman CM, Kolansky DM, Spinler SA.
    Pharmacotherapy; 2006 Aug; 26(8):1086-90. PubMed ID: 16863485
    [Abstract] [Full Text] [Related]

  • 12. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery.
    Bergqvist D.
    Br J Surg; 2004 Aug; 91(8):965-74. PubMed ID: 15286956
    [Abstract] [Full Text] [Related]

  • 13. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
    Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ, PREVENT Medical Thromboprophylaxis Study Group.
    Circulation; 2004 Aug 17; 110(7):874-9. PubMed ID: 15289368
    [Abstract] [Full Text] [Related]

  • 14. Venous thromboembolism prevention in acutely ill nonsurgical patients.
    Brophy DF, Dougherty JA, Garrelts JC, Parish RC, Rivey MP, Stumpf JL, Taylor CT, Mathis AS.
    Ann Pharmacother; 2005 Aug 17; 39(7-8):1318-24. PubMed ID: 15941823
    [Abstract] [Full Text] [Related]

  • 15. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
    Balibrea JL, Altimiras J, Larruzea I, Gómez-Outes A, Martínez-González J, Rocha E, Bemiparin Cooperative Study Group in Surgery for Cancer.
    Int J Surg; 2007 Apr 17; 5(2):114-9. PubMed ID: 17448976
    [Abstract] [Full Text] [Related]

  • 16. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
    Nishioka J, Goodin S.
    J Oncol Pharm Pract; 2007 Jun 17; 13(2):85-97. PubMed ID: 17873108
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis.
    Själander A, Jansson JH, Bergqvist D, Eriksson H, Carlberg B, Svensson P.
    J Intern Med; 2008 Jan 17; 263(1):52-60. PubMed ID: 18088252
    [Abstract] [Full Text] [Related]

  • 18. Prophylaxis strategies for patients with acute venous thromboembolism.
    Tapson VF.
    Am J Manag Care; 2001 Nov 17; 7(17 Suppl):S524-31; discussion S531-4. PubMed ID: 11732663
    [Abstract] [Full Text] [Related]

  • 19. Economic evaluation of enoxaparin as prophylaxis against venous thromboembolism in seriously ill medical patients: a US perspective.
    de Lissovoy G, Subedi P.
    Am J Manag Care; 2002 Dec 17; 8(12):1082-8. PubMed ID: 12500884
    [Abstract] [Full Text] [Related]

  • 20. Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care?
    Burris HA.
    Semin Oncol; 2006 Apr 17; 33(2 Suppl 4):S3-16; quiz S41-2. PubMed ID: 16638456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.